Solana ( SOL 3.96%) holders are no stranger to risk, given the coin's wild volatility and its occasional use by unsavory ...

The tech market took it on the chin on Wednesday as the trade war picked up steam and the Federal Reserve sounds like it's ...

Lucid stock is down about 25% year to date with today's drop. News from the company yesterday was positive, though. Lucid is ...

For the inaugural quarter of 2025, Progressive's net premiums earned (essentially, total revenue) was $22.2 billion, ...

The analyst behind the reduction was Wedbush's David Nierengarten, who now believes NovoCure is worth $27 per share. That's slightly below his previous price target of $29. As the change isn't ...